In reply [3]

Journal of Clinical Oncology

Volumn 25, Issue 13, 2007, Pages 1815-

  Henke, Michael ^a   Mattern, Dominik ^b   Pajonk, Frank ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; HEAT SHOCK PROTEIN 70; RECOMBINANT ERYTHROPOIETIN; SC 695 ANTIBODY; UNCLASSIFIED DRUG;

CANCER CELL; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CROSS REACTION; HUMAN; IRON THERAPY; LABORATORY DIAGNOSIS; LETTER; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 34249069794     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.9283     Document Type: Letter

References (9)

1. Henke M, Mattern D, Pepe M, et al: Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24:4708-4713, 2006
2. Elliott S, Busse L, Bass MB, et al: Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107:1892-1895, 2006
3. Henke M, Verma A, Acs G, et al: Erythropoietin receptors on cancer cells: Exciting perspectives, difficult to appreciate. Blood 108:1107-1109, 2006
4. Brown WM, Maxwell P, Graham AN, et al: Erythropoietin receptor expression in non-small cell lung carcinoma: A question of antibody specificity. Stem Cells 25:718-722, 2006
5. Pajonk F, Weil A, Sommer A, et al: The erythropoietin-receptor pathway modulates survival of cancer cells. Oncogene 23:8987-8991, 2004
6. Henke M, Laszig R, Frommhold H: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:81-82, 2004
7. Henke M, Laszig R, Rube C, et al: Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 362:1255-1260, 2003
8. Leyland-Jones B, Semiglazov V, Pawlicki M, et al: Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study. J Clin Oncol 23:5960-5972, 2005
9. Lai SY, Grandis JR: Understanding the presence and function of erythropoietin receptors on cancer cells. J Clin Oncol 24:4675-4676, 2006